You can buy or sell KRTX and other stocks, options, ETFs, and crypto commission-free!
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.
52 Week High
52 Week Low
— per share
Expected May 7, Pre-Market